4-Methylpyridine-3-boronic acid pinacol ester

Product Information

Molecular Formula:
C12H18BNO2
Molecular Weight:
219.09
Description
4-Methylpyridine-3-boronic acid pinacol ester is a biomedical product used in the treatment of various diseases. It acts as a potent inhibitor for specific enzymes related to cancer and autoimmune disorders, making it an effective therapeutic option. Additionally, this compound plays a crucial role in drug discovery and development processes, aiding in the design and synthesis of novel pharmaceutical agents.
Synonyms
4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine; 4-Methylpyridine-3-boronic acid pinacol ester; 4-methyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine; (4-METHYLPYRIDIN-3-YL)BORONIC ACID PINACOL ESTER; 4-Methylpyridine-3-boronic acid pinacol ester, 96%; Z1336745167; 2-(4-Methyl-3-pyridyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; Pyridine, 4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
IUPAC Name
4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Canonical SMILES
B1(OC(C(O1)(C)C)(C)C)C2=C(C=CN=C2)C
InChI
InChI=1S/C12H18BNO2/c1-9-6-7-14-8-10(9)13-15-11(2,3)12(4,5)16-13/h6-8H,1-5H3
InChI Key
GZYZXNXJTPRMKF-UHFFFAOYSA-N
Melting Point
103-107 °C
Purity
96%
Storage
−20°C

Computed Properties

Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
1
Exact Mass
219.1430590 g/mol
Monoisotopic Mass
219.1430590 g/mol
Topological Polar Surface Area
31.4Ų
Heavy Atom Count
16
Formal Charge
0
Complexity
252
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
CN-113912595-A Compound containing thiazole or thiadiazole structure and application thereof 2021-10-12
US-2022002299-A1 Tricyclic pyridone compounds as jak2 v617f inhibitors 2020-07-02
WO-2022006456-A1 Tricyclic pyridone compounds as jak2 v617f inhibitors 2020-07-02
WO-2021159993-A1 Inhibitors of interleukin-1 receptor associated kinase (irak) /fms-like receptor tyrosine kinase (flt3), pharmaceutical products thereof, and methods thereof 2020-02-14
US-2021269434-A1 Tricyclic compounds as inhibitors of kras 2020-01-10
WO-2021142252-A1 Tricyclic compounds as inhibitors of kras 2020-01-10
WO-2021004535-A1 Cinnolines as inhibitors of hpk 1 2019-07-11
WO-2021004547-A1 Heterocyclic compounds as inhibitors of hpk1 2019-07-11
WO-2020177629-A1 Spiro-substituted pyrimidine-fused cyclic compound, preparation method therefor and medical use thereof 2019-03-01
TW-202031644-A Benzimidazole derivative 2018-11-06
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2025 BOC Sciences. All rights reserved.
Top
0
Inquiry Basket

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x